Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Yamaguchi

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 14, 2011
[Multiple infectious intracranial lesions of Mycobacterium genavense in an immunocompromised patient]Haruto Uchino, Shunsuke Terasaka, Shigeru Yamaguchi, et al.
Journal of Neurosurgery|February 9, 2024
Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edemaRyosuke Sawaya, Shigeru Yamaguchi, Yukitomo Ishi, et al.
Photochemistry and Photobiology|May 25, 2010
Novel photodynamic therapy using water-dispersed TiO2-polyethylene glycol compound: evaluation of antitumor effect on glioma cells and spheroids in vitroShigeru Yamaguchi, Hiroyuki Kobayashi, Takuhito Narita, et al.
Neurologia Medico-Chirurgica|March 4, 2021
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective AnalysisShigeru Yamaguchi, Hiroaki Motegi, Yukitomo Ishi, et al.
Journal of Chemotherapy (Florence, Italy)|February 19, 2019
Long-Term Evaluation of Combination Treatment of Single Agent HD-MTX Chemotherapy up to Three Cycles and Moderate Dose Whole Brain Irradiation for Primary CNS LymphomaHiroyuki Kobayashi, Shigeru Yamaguchi, Hiroaki Motegi, et al.
No Shinkei Geka. Neurological Surgery|January 28, 2012
[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma]Yuuta Kamoshima, Hiroaki Motegi, Shunsuke Terasaka, et al.
Physical Chemistry Chemical Physics : PCCP|August 11, 2016
ZnO nanorods prepared via ablation of Zn with millisecond laser in liquid mediaMitsuhiro Honda, Taku Goto, Tatsuki Owashi, et al.
No Shinkei Geka. Neurological Surgery|October 7, 2004
[Joint therapy of a dural arteriovenous fistula in the transverse-sigmoid sinus using surgical excision and direct sinus packing: a case report]Shigeru Yamaguchi, Satoshi Kuroda, Satoshi Ushikoshi, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 7, 2012
Primary rhabdoid tumor with low grade glioma component of the central nervous system in a young adultShogo Endo, Shunsuke Terasaka, Shigeru Yamaguchi, et al.
Brain Tumor Pathology|July 4, 2012
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapyHiroaki Motegi, Yuuta Kamoshima, Shunsuke Terasaka, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 14, 2011
[Multiple infectious intracranial lesions of Mycobacterium genavense in an immunocompromised patient]Haruto Uchino, Shunsuke Terasaka, Shigeru Yamaguchi, et al.
Journal of Neurosurgery|February 9, 2024
Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edemaRyosuke Sawaya, Shigeru Yamaguchi, Yukitomo Ishi, et al.
Photochemistry and Photobiology|May 25, 2010
Novel photodynamic therapy using water-dispersed TiO2-polyethylene glycol compound: evaluation of antitumor effect on glioma cells and spheroids in vitroShigeru Yamaguchi, Hiroyuki Kobayashi, Takuhito Narita, et al.
Neurologia Medico-Chirurgica|March 4, 2021
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective AnalysisShigeru Yamaguchi, Hiroaki Motegi, Yukitomo Ishi, et al.
Journal of Chemotherapy (Florence, Italy)|February 19, 2019
Long-Term Evaluation of Combination Treatment of Single Agent HD-MTX Chemotherapy up to Three Cycles and Moderate Dose Whole Brain Irradiation for Primary CNS LymphomaHiroyuki Kobayashi, Shigeru Yamaguchi, Hiroaki Motegi, et al.
No Shinkei Geka. Neurological Surgery|January 28, 2012
[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma]Yuuta Kamoshima, Hiroaki Motegi, Shunsuke Terasaka, et al.
Physical Chemistry Chemical Physics : PCCP|August 11, 2016
ZnO nanorods prepared via ablation of Zn with millisecond laser in liquid mediaMitsuhiro Honda, Taku Goto, Tatsuki Owashi, et al.
No Shinkei Geka. Neurological Surgery|October 7, 2004
[Joint therapy of a dural arteriovenous fistula in the transverse-sigmoid sinus using surgical excision and direct sinus packing: a case report]Shigeru Yamaguchi, Satoshi Kuroda, Satoshi Ushikoshi, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 7, 2012
Primary rhabdoid tumor with low grade glioma component of the central nervous system in a young adultShogo Endo, Shunsuke Terasaka, Shigeru Yamaguchi, et al.
Brain Tumor Pathology|July 4, 2012
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapyHiroaki Motegi, Yuuta Kamoshima, Shunsuke Terasaka, et al.
Pageof 17